Outside of RCC, lower ITGAL expression in non-small-cell lung cancer was associated with worse prognosis, with higher immune infiltration in malignant tissues.32 Similar trends were seen in patients with melanoma.33 Here, ITGAL is linked to non-small cell lung carcinoma.